Skip to content
Recall Observatory FDA recall evidence

Drug product

Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA

D-0629-2020

December 10, 2019

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 84463
Status
Terminated
Classification
Class III
Quantity
3,726 bottles
Official record key
drug-enforcement:D-0629-2020

Official wording

Reason: Failed Dissolution Specifications: High out of specification result observed at stability studies.

Code information: Lot #: H901787, H901788, Exp March 2021

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification